He studied Technical Engineering in Computing Management at the University of Burgos. He developed most of his profesional career in the R&D automotive field until 2009.
He was diagnosed Hodgkin's Lymphoma in 2008. Due to this circumstance, he decided to become involved in patient advocacy, first as a volunteer in his home town, and later on moving to Madrid to start working on a profesional full time basis in 2009. Between 2009 and 2013 he worked at the Spanish Group for Lymphoma, Myeloma and Leukaemia Association and for the Spanish Group for Cancer Patients, first as Technical Manager and later as International Affairs Manager.
In 2014, he joined the executive office of Myeloma Patients Europe as Project, a European (MPE) umbrella federation of multiple myeloma patients, as Project Manager. During the next years, the organisations undergoes a sustainable growth in terms of governance and accountability. As part of his duties at MPE his main focus areas were patient involvement in clinical research, access, European health policy and capacity building among member organisations.
In September 2018, he started providing consultance to the European group of lung cancer patients, Lung Cancer Europe (LuCE). His main role is to develop a set of projects aiming to improve access to treatment and care for lung cancer patients, raise awareness about the disease and improve the skills of the European member groups of LuCE to help them tailor initiatives to improve support, advocacy and outcomes in their own countries. In April 2023, Alfonso was promoted to a new role as Policy Officer in Lung Cancer Europe (LuCE)
During all his professional career, he has been involved in several multistakeholder workgroups and advisory boards, both at a national and international level.
He is currently based in Madrid.
Updated: July 2024